Cribstone Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Cribstone Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-40	Closed	-$4K	–	365
2020 Q1	$4K	Buy	+40	New	+$4.61K	﹤0.01%	269
2019 Q4	–	Sell	-165	Closed	-$16K	–	442
2019 Q3	$16K	Sell	165 -600	-78%	-$62.8K	0.01%	365
2019 Q2	$83K	Hold	765	–	–	0.05%	190
2019 Q1	$86K	Hold	765	–	–	0.05%	178
2018 Q4	$74K	Hold	765	–	–	0.04%	204
2018 Q3	$93K	Buy	765 +61	+9%	+$7.18K	0.04%	198
2018 Q2	$77K	Buy	704 +60	+9%	+$6.42K	0.04%	215
2018 Q1	$69K	Buy	644 +629	+4,193%	+$69.7K	0.03%	219
2017 Q4	$2K	Sell	15 -15	-50%	-$1.6K	﹤0.01%	794
2017 Q3	$3K	Hold	30	–	–	﹤0.01%	645
2017 Q2	$3K	Buy	+30	New	+$2.96K	﹤0.01%	636

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cribstone Capital Management's IBB Position: Q2 2020 in Review

Cribstone Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 40 shares — an estimated $4K sold.

Cribstone Capital Management first reported a position in IBB in Q2 2017 and held it in 11 quarters. The position peaked at $93K in Q3 2018. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

Cribstone Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
Cribstone Capital Management sold 40 iShares Biotechnology ETF shares in Q2 2020, an estimated $4K.
Cribstone Capital Management first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 11 quarters.
Cribstone Capital Management's iShares Biotechnology ETF position peaked at $93K in Q3 2018.
766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Cribstone Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.